Previous Page  30 / 30
Information
Show Menu
Previous Page 30 / 30
Page Background

Page 68

Notes:

allied

academies

Journal of Neurology and Neurorehabilitation Research | Volume 3

November 26-27, 2018 | Dubai, UAE

Spine and Spine Disorders

Addiction Research and Therapy

3rd International Conference on

International Conference on

Joint Event

&

Contribution of the blood biochemical factors, body composition and genetics to low back pain

manifestation in complex Arab pedigrees

Nader Tarabeih

1

, Adel Shalata

2

, Svetlana Trofimov

1

, Alexander Kalinkovich

1

and

Gregory Livshits

1

1

Tel-Aviv University, Israel

2

The Simon Winter Institute for Human Genetics, Bnai Zion Medical Center, Israel

Objective:

Evidence has suggested that the development of

low back pain (LBP) is often associated with obesity, muscle

loss and sarcopenia. The mechanisms of these associations

remain unclear. To clarify this, we measured circulating levels

of a selected panel of soluble factors, presumably involved in

the pathogenesis of obesity and sarcopenia, and correlated

themwith several LBP-related characteristics, considering body

composition, familial effects and other relevant covariates.

Methods:

The cross-sectional study comprised of 1078 Arab-

Israeliindividuals.Patientswererecruitedbasedonself-reported

LBP. Body composition variables (including fat and muscle mass

measurements) assessed by bioelectrical impedance analysis

(BIA) and anthropometricmeasurements, scoliosis asmeasured

by scoliometer, and plasma levels of several cytokines by ELISA

methodwerecollected.Statisticalanalysesaccountedforfamilial

compositionof the sample andpossibleputative genetic effects.

Results:

LBP affected individuals were significantly older, and

showed increased obesity, decreased skeletal mass, and a

significant correlation with spinal scoliosis when compared

to healthy controls. Putative genetic factors were significantly

associated with the age of onset of LBP, regardless of sciatic

pain. Using univariate analyses, plasma concentrations of GDF-

15, leptin, chemerin and follistatinwere found to be significantly

elevated in the LBP-affected groups (with or without sciatic

pain) and were highly significantly (p<0.001) associated with

other LBP-related phenotypes, specifically, disease duration,

disability and physician consultation. However, following

adjustment for age, sex, body composition, and putative genetic

factors, only associations between GDF-15, LBP disability

and medical consulting phenotypes, remained significant.

Conclusions:

For the first time, we report a significant

and independent association between plasma GDF-15

concentrationsandLBP-associateddisability.Longitudinalstudies

are recommended to determine whether GDF-15 could be a

novel therapeutic target for prevention and/or treatment of LBP.

Speaker Biography

Nader Tarabeih is a PhD student in the Department of Anatomy and Anthropology

in the Tel-Aviv University, under the supervision of professor Gregory Livshits. His

PhD project on Complex Arab pedigrees was consisting of 1104 volunteer individuals

belonging to 28 complex Arab pedigrees with high prevalence of Low Back Pain (LBP).

The advantage of a huge sample allowed Nader to accurately estimate contribution

of the putative genetic factors to the manifestation of LBP, represented in his first

manuscript entitled “Genetic, Body Composition and Demographic Risk Factors of Low

Back Pain in Complex Arab Pedigrees” submitted for publication in The Clinical Journal

of pain. The second manuscript, in which detailed “Growth and differentiation factor

15 (GDF-15) is a biomarker for low back pain-associated disability”, is in preparation.

Nader recently participated in BIRAX Ageing Council 2018 which was in London.

e:

nadertar@gmail.com